Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Checkpoint Inhibitors Competitive Landscape Report 2026: Comprehensive Insights About 50+ Companies and 60+ Drugs
02/18 11:49 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors
12/22 09:01 am
Benzinga
Read moreTransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout
10/08 10:48 am
Benzinga
Read moreUS Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert
05/05 06:27 am
Benzinga
Read moreWhy Transcode Therapeutics (RNAZ) Stock Is Down 60% - Benzinga
07/23 01:26 pm
Benzinga
Read moreBeat the Market Like Zacks: Goldman Sachs, Micron, Amgen in Focus
06/10 08:07 am
Zacks Investment Research
Read moreNasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
06/10 07:00 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
05/29 09:15 am
GlobeNewswire Inc.
Read moreSuccessful Penny Stocks Trader Tips, 3 To Use
05/12 06:18 am
PennyStocks
Read moreTransCode Therapeutics Reports 2023 Results; Provides Business Update
04/03 09:10 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
03/28 08:30 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
03/11 09:00 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress
03/06 05:15 pm
GlobeNewswire Inc.
Read moreNasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement and Continued Listing on The Nasdaq Stock Market
01/31 05:05 pm
GlobeNewswire Inc.
Read moreTransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
01/29 09:30 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Announces Closing of $7.25 Million Public Offering
01/22 05:45 pm
GlobeNewswire Inc.
Read moreTransCode (RNAZ) Down 50% on Issue of New Common Stock
01/19 02:09 pm
Zacks Investment Research
Read moreTransCode Therapeutics Announces Pricing of $7.25 Million Public Offering
01/18 02:27 pm
GlobeNewswire Inc.
Read moreTransCode Therapeutics Reports Further Restructuring to Reduce Expenses and Increased Focus on Planned Phase 1 Clinical Trial, Retirement of CEO
01/12 05:05 pm
GlobeNewswire Inc.
Read moreTransCode Therapeutics Publishes Open Letter Outlining Company’s Progress and Objectives
01/04 09:05 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138
12/12 09:30 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Announces Closing of $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
12/04 05:10 pm
GlobeNewswire Inc.
Read moreTransCode Therapeutics Announces $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
11/30 03:53 pm
GlobeNewswire Inc.
Read moreTransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update
11/14 05:30 pm
GlobeNewswire Inc.
Read moreTransCode Therapeutics Withdraws Public Offering
10/30 04:33 pm
GlobeNewswire Inc.
Read moreNasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings
10/27 09:43 am
Benzinga
Read moreNasdaq Panel Grants TransCode Therapeutics Extension for Continued Listing on The Nasdaq Stock Market Subject to Conditions
10/27 08:00 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Announces Public Offering of Common Stock
10/26 04:19 pm
GlobeNewswire Inc.
Read moreTransCode Therapeutics Announces Preliminary Clinical Results in First Patient in Phase 0 Clinical Study with Lead Therapeutic Candidate, TTX-MC138
10/24 08:00 am
GlobeNewswire Inc.
Read moreTransCode Therapeutics Announces Closing of $8.5 Million Public Offering
09/28 04:02 pm
GlobeNewswire Inc.
Read moreCrude Oil Moves Higher; Cintas Earnings Top Estimates
09/26 12:04 pm
Benzinga
Read moreDow Tumbles 150 Points; US House Prices Rise in July
09/26 09:46 am
Benzinga
Read moreTransCode Therapeutics Announces Pricing of $8 Million Public Offering
09/25 08:01 pm
GlobeNewswire Inc.
Read moreAmazon Invests Up To $4B In ChatGPT Competitor, Hollywood Writers Accept Preliminary Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
09/25 10:58 am
Benzinga
Read more